新药目录
这里收录了新药通持续跟踪到的在研新药与疗法,共 591 款。点开任意一款,可以看到它目前在全球哪些研究中招募患者、针对什么疾病、由哪家药企研发,以及中国患者可以走的申请途径。
- Carboplatin
适应疾病:Metastatic Non-small Cell Lung Cancer With MTAP Deletion、Non-small Cell Lung Cancer、Carcinoma, Non-Small-Cell Lung
研发方:Bristol-Myers Squibb
- Pembrolizumab
适应疾病:Metastatic Non-small Cell Lung Cancer With MTAP Deletion、Non-small Cell Lung Cancer、Carcinoma, Non-Small-Cell Lung
研发方:Bristol-Myers Squibb
- Cyclophosphamide
适应疾病:Metastatic Colorectal Cancer、Metastatic Pancreatic Cancer、Metastatic Ovarian Cancer
研发方:National Cancer Institute (NCI)
- Rituximab
适应疾病:Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma、Leukemia, Lymphocytic, Chronic, B-Cell、Leukemia, Chronic Lymphocytic
研发方:Hoffmann-La Roche
- Venetoclax
适应疾病:Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma、Leukemia, Lymphocytic, Chronic, B-Cell、Leukemia, Chronic Lymphocytic
研发方:Hoffmann-La Roche
- Azacitidine
适应疾病:Recurrent Acute Myeloid Leukemia、Refractory Acute Myeloid Leukemia、Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
研发方:City of Hope Medical Center
- Bevacizumab
适应疾病:Advanced Endometrial Carcinoma、Recurrent Endometrial Carcinoma、Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
研发方:National Cancer Institute (NCI)
- Cetuximab
适应疾病:Metastatic Colorectal Adenocarcinoma、Recurrent Colorectal Adenocarcinoma、Refractory Colorectal Adenocarcinoma
研发方:National Cancer Institute (NCI)
- Cisplatin
适应疾病:Metastatic Non-small Cell Lung Cancer With MTAP Deletion、Intrahepatic Cholangiocarcinoma、Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
研发方:Bristol-Myers Squibb
- Dexamethasone
适应疾病:Multiple Myeloma、Relapsed/Refractory Multiple Myeloma、Relapsed Refractory Multiple Myeloma (RRMM)
研发方:C4 Therapeutics, Inc.
- Nivolumab
适应疾病:Non-small Cell Lung Cancer、Gastric / Gastroesophageal Junction Adenocarcinoma、Advanced Solid Tumor
研发方:Bristol-Myers Squibb
- Tirzepatide
适应疾病:Obesity、Menopause Hot Flashes、Diabetes Mellitus, Type 1
研发方:Mayo Clinic
- Doxorubicin
适应疾病:Peripheral T Cell Lymphoma、DLBCL - Diffuse Large B Cell Lymphoma、Angioimmunoblastic T-cell Lymphoma
研发方:M.D. Anderson Cancer Center
- Durvalumab
适应疾病:Intrahepatic Cholangiocarcinoma、Endometrial Cancer、Epithelial Ovarian Cancer
研发方:Francesco De Cobelli
- Fludarabine
适应疾病:Metastatic Colorectal Cancer、Metastatic Pancreatic Cancer、Metastatic Ovarian Cancer
研发方:National Cancer Institute (NCI)
- Gemcitabine
适应疾病:Intrahepatic Cholangiocarcinoma、Breast Neoplasms、Hodgkin Lymphoma
研发方:Francesco De Cobelli
- Mosunetuzumab
适应疾病:Lupus、Systemic Lupus Erythematosus、Lupus Nephritis
研发方:Hoffmann-La Roche
- Vincristine
适应疾病:Diffuse Large B-cell Lymphoma、Peripheral T Cell Lymphoma、DLBCL - Diffuse Large B Cell Lymphoma
研发方:The University of Texas Health Science Center at San Antonio
- 5-Fluorouracil
适应疾病:Colon Adenocarcinoma、Rectal Adenocarcinoma、Endometrial Cancer
研发方:Merck Sharp & Dohme LLC
- Acalabrutinib
适应疾病:Recurrent Chronic Lymphocytic Leukemia、Recurrent Small Lymphocytic Lymphoma、Refractory Chronic Lymphocytic Leukemia
研发方:Fred Hutchinson Cancer Center
- Alisertib
适应疾病:Small Cell Lung Cancer ( SCLC )
研发方:Puma Biotechnology, Inc.
- Cytarabine
适应疾病:Autologous Stem Cell Transplant、Classic Hodgkin Lymphoma、Acute Myeloid Leukemia With Gene Mutations
研发方:Masonic Cancer Center, University of Minnesota
- Docetaxel
适应疾病:Non Small Cell Lung Cancer、c-MET、NSCLC (Non-small Cell Lung Cancer)
研发方:AbbVie
- Etavopivat
适应疾病:Sickle Cell Disease、Thalassemia
研发方:Novo Nordisk A/S
- Etoposide
适应疾病:Autologous Stem Cell Transplant、Classic Hodgkin Lymphoma、Non-Hodgkin Lymphoma
研发方:Masonic Cancer Center, University of Minnesota
- Orforglipron
适应疾病:Diabetes Mellitus, Type 2、Urinary Incontinence,Stress、Atherosclerosis Cardiovascular Disease
研发方:Eli Lilly and Company
- Psilocybin
适应疾病:Major Depression、Depression、Parkinson's Disease (PD)
研发方:VA Office of Research and Development
- Pumitamig
适应疾病:Locally Advanced Non-Small Cell Lung Cancer (NSCLC)、Metastatic Non-Small Cell Lung Cancer (NSCLC)、Breast Neoplasms
研发方:Bristol-Myers Squibb
- Zanubrutinib
适应疾病:Lymphoma、Mantle Cell Lymphoma、Follicular Lymphoma
研发方:M.D. Anderson Cancer Center
- Apixaban
适应疾病:Atrial Fibrillation、Venous Thromboembolism (VTE)、Multiple Myeloma
研发方:VA Office of Research and Development
- Capecitabine
适应疾病:Breast Neoplasms、Metastatic Colorectal Carcinoma、Metastatic Malignant Solid Neoplasm
研发方:Merck Sharp & Dohme LLC
- Daraxonrasib
适应疾病:Non-Small Cell Lung Cancer (NSCLC)、Colorectal Cancer、Pancreatic Ductal Adenocarcinoma
研发方:Revolution Medicines, Inc.
- IBI3016
适应疾病:Hypertension
研发方:Innovent Biologics (Suzhou) Co. Ltd.
- laroprovstat/rosuvastatin
适应疾病:Hypercholesterolaemia
研发方:AstraZeneca
- Lenalidomide
适应疾病:Hodgkin Lymphoma、B-Cell Lymphoma、Relapsed B-cell NHL
研发方:M.D. Anderson Cancer Center
- Oxaliplatin
适应疾病:Pancreatic Cancer、Metastatic Pancreatic Cancer、Metastatic Pancreatic Adenocarcinoma
研发方:Astellas Pharma Global Development, Inc.
- Pemetrexed
适应疾病:Non-small Cell Lung Cancer、Carcinoma, Non-Small-Cell Lung、Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
研发方:Bristol-Myers Squibb
- PMG1016
适应疾病:Chronic Kidney Disease
研发方:Pulmongene Ltd.
- Pomalidomide
适应疾病:Multiple Myeloma、Smoldering Multiple Myeloma、Immunoglobulin Light-chain Amyloidosis
研发方:Janssen Research & Development, LLC
- Prednisone
适应疾病:Prostate Cancer、Prostatic Neoplasms、Peripheral T Cell Lymphoma
研发方:Merck Sharp & Dohme LLC
- Ruxolitinib
适应疾病:Myelofibrosis、Primary Myelofibrosis (PMF)、Post-polycythemia Vera Myelofibrosis (PPV-MF)
研发方:Sumitomo Pharma America, Inc.
- Zenagamtide
适应疾病:Overweight、Obesity
研发方:Novo Nordisk A/S
- Abiraterone
适应疾病:PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy、Castration Levels of Testosterone、Metastatic Prostatic Adenocarcinoma
研发方:Novartis Pharmaceuticals
- ALX2004
适应疾病:NSCLC (Advanced Non-small Cell Lung Cancer)、HNSCC、CRC (Colorectal Cancer)
研发方:ALX Oncology Inc.
- anifrolumab
适应疾病:Systemic Lupus Erythematosus、Cardiovascular Disease、Premature Atherosclerosis
研发方:National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- AZD8965
适应疾病:Idiopathic Pulmonary Fibrosis (IPF)
研发方:AstraZeneca
- Blinatumomab
适应疾病:Acute Lymphoblastic Leukemia、Philadelphia Chromosome-Positive、Acute Lymphoblastic Leukemia (ALL)
研发方:Northside Hospital, Inc.
- BNT162b2
适应疾病:COVID-19 Vaccines
研发方:BioNTech SE
- Daratumumab
适应疾病:Multiple Myeloma、Smoldering Multiple Myeloma、Immunoglobulin Light-chain Amyloidosis
研发方:Canadian Cancer Trials Group
- Enzalutamide
适应疾病:PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy、Prostate Adenocarcinoma、Metastatic Castration-Resistant Prostate Cancer
研发方:Novartis Pharmaceuticals
- fluorouracil
适应疾病:Pancreatic Cancer、Metastatic Pancreatic Cancer、Metastatic Pancreatic Adenocarcinoma
研发方:Astellas Pharma Global Development, Inc.
- Ibrutinib
适应疾病:Relapsed Hematologic Malignancy、Refractory Hematologic Malignancy、Relapsed Primary Central Nervous System Lymphoma
研发方:Curis, Inc.
- Lenvatinib
适应疾病:Hepatocellular Cancer、Squamous-Cell Non-Small Cell Lung Cancer、Recurrent Endometrial Cancer
研发方:AbbVie
- Leucovorin
适应疾病:Pancreatic Cancer、Metastatic Pancreatic Cancer、Metastatic Pancreatic Adenocarcinoma
研发方:Astellas Pharma Global Development, Inc.
- Mezigdomide
适应疾病:Leukemia、Acute Leukemia、Relapse Leukemia
研发方:Memorial Sloan Kettering Cancer Center
- Mirikizumab
适应疾病:Colitis, Ulcerative、Crohn Disease、Ulcerative Colitis
研发方:Eli Lilly and Company
- Ontunisertib
适应疾病:Fibrostenotic Crohn's Disease
研发方:Agomab Spain S.L.U.
- Paclitaxel
适应疾病:Breast Neoplasms、Triple Negative Breast Neoplasms、HR Low-Positive/HER2-Negative Breast Neoplasms
研发方:Merck Sharp & Dohme LLC
- Pirtobrutinib
适应疾病:Mantle Cell Lymphoma、Chronic Lymphocytic Leukemia、Small Lymphocytic Lymphoma
研发方:H. Lee Moffitt Cancer Center and Research Institute
- Rimegepant
适应疾病:Acute Treatment of Migraine、Migraine
研发方:Pfizer
- Semaglutide
适应疾病:Overweight、Obesity、Type 2 Diabetes
研发方:Novo Nordisk A/S
- -FAPI-74
适应疾病:Tuberculosis, Pulmonary、Allogeneic Stem Cell Transplantation、Lung Allograft Transplantation
研发方:University of Pennsylvania
- Afimkibart
适应疾病:Rheumatoid Arthritis、Active Ulcerative Colitis
研发方:Hoffmann-La Roche
- Aldesleukin
适应疾病:Metastatic Colorectal Cancer、Metastatic Pancreatic Cancer、Metastatic Ovarian Cancer
研发方:National Cancer Institute (NCI)
- AZD5492
适应疾病:Systemic Lupus Erythematosus、Idiopathic Inflammatory Myopathies、Rheumatoid Arthritis
研发方:AstraZeneca
- Balstilimab
适应疾病:Colorectal Adenocarcinoma、Stage II Colorectal Cancer AJCC v8、Stage III Colorectal Cancer AJCC v8
研发方:National Cancer Institute (NCI)
- Baricitinib
适应疾病:Diabetes Mellitus, Type 1、Long COVID、Sars-CoV-2 Infection
研发方:Eli Lilly and Company
- Belinostat
适应疾病:Carcinoma, Neuroendocrine、Tumor, Neuroendocrine、Tumors, Neuroendocrine
研发方:National Cancer Institute (NCI)
- benralizumab
适应疾病:Severe Eosinophilic Asthma、Asthma、Eosinophilic Granulomatosis With Polyangiitis (EGPA)
研发方:AstraZeneca
- Bicalutamide
适应疾病:Castration Levels of Testosterone、Metastatic Prostatic Adenocarcinoma、Stage IV Prostate Cancer AJCC v8
研发方:SWOG Cancer Research Network
- Bortezomib
适应疾病:Acute Myeloid Leukemia、TP53、Relapsed or Refractory Multiple Myeloma
研发方:Masonic Cancer Center, University of Minnesota
- Botensilimab
适应疾病:Colorectal Adenocarcinoma、Stage II Colorectal Cancer AJCC v8、Stage III Colorectal Cancer AJCC v8
研发方:National Cancer Institute (NCI)
- Cabozantinib
适应疾病:Metastatic Digestive System Neuroendocrine Tumor G1、Metastatic Digestive System Neuroendocrine Tumor G2、Unresectable Digestive System Neuroendocrine Tumor G1
研发方:National Cancer Institute (NCI)
- Cadonilimab
适应疾病:Gastric / Gastroesophageal Junction Adenocarcinoma、Gastric Cancer、Gastroesophageal-junction Cancer
研发方:Akeso
- Cagrilintide
适应疾病:Obesity、Overweight
研发方:Novo Nordisk A/S
- Carfilzomib
适应疾病:Multiple Myeloma、Plasma Cell Leukemia
研发方:Hackensack Meridian Health
- Curcumin
适应疾病:Multiple Myeloma, Smoldering、Multiple Myeloma、Monoclonal Gammopathy of Undetermined Significance
研发方:Memorial Sloan Kettering Cancer Center
- Depemokimab
适应疾病:Pulmonary Disease, Chronic Obstructive
研发方:GlaxoSmithKline
- Donanemab
适应疾病:Cognitive Dysfunction、Lewy Body Disease、Synucleinopathies
研发方:Eli Lilly and Company
- Dulaglutide
适应疾病:Diabetes Mellitus, Type 2、Diabetes Mellitus, Type 1、Endothelial Dysfunction
研发方:Eli Lilly and Company
- Efgartigimod
适应疾病:AChR-Ab Seropositive Generalized Myasthenia Gravis、Myasthenia Gravis、MG
研发方:argenx
- Efgartigimod PH20
适应疾病:Systemic Sclerosis (SSc)、Generalized Myasthenia Gravis
研发方:argenx
- Elotuzumab
适应疾病:Relapsed Refractory Multiple Myeloma (RRMM)、Myeloma、Multiple Myeloma
研发方:Regeneron Pharmaceuticals
- Emicizumab
适应疾病:Hemophilia A
研发方:Emory University
- ENV-294
适应疾病:Asthma、Atopic Dermatitis (AD)
研发方:Enveda Therapeutics
- EVO756
适应疾病:Migraine
研发方:Evommune, Inc.
- Frexalimab
适应疾病:Kidney Transplant Rejection
研发方:Sanofi
- G-CSF
适应疾病:Acute-On-Chronic Liver Failure、Alcoholic Hepatitis、Liver Cirrhosis, Alcoholic
研发方:Yaqrit Ltd
- Glofitamab
适应疾病:Non-Hodgkin Lymphoma, B-cell、B Cell Lymphoma
研发方:Ryvu Therapeutics SA
- GSK5784283
适应疾病:Pulmonary Disease, Chronic Obstructive、Asthma
研发方:GlaxoSmithKline
- Guselkumab
适应疾病:Crohn's Disease
研发方:Janssen Research & Development, LLC
- Icotrokinra
适应疾病:Colitis, Ulcerative、Crohn Disease
研发方:Janssen Research & Development, LLC
- Ipilimumab
适应疾病:Diffuse Astrocytoma, IDH-Mutant、Glioblastoma, IDH-wildtype、Brain Metastases, Adult
研发方:Neonc Technologies, Inc.
- Irinotecan
适应疾病:Pancreatic Cancer、Metastatic Pancreatic Cancer、Metastatic Pancreatic Adenocarcinoma
研发方:Astellas Pharma Global Development, Inc.
- Isatuximab
适应疾病:Multiple Myeloma
研发方:Canadian Cancer Trials Group
- Ivosidenib
适应疾病:Acute Myeloid Leukemia With Gene Mutations、Acute Myeloid Leukemia
研发方:PETHEMA Foundation
- JNJ-79635322
适应疾病:Multiple Myeloma、Smoldering Multiple Myeloma、Immunoglobulin Light-chain Amyloidosis
研发方:Janssen Research & Development, LLC
- KarXT
适应疾病:Alzheimer Disease、Psychosis Associated With Alzheimer's Disease
研发方:Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Letrozole
适应疾病:Advanced Solid Tumor、HR+/HER2- Breast Cancer、HR+, HER2-, Advanced Breast Cancer
研发方:Avenzo Therapeutics, Inc.
- LY3971297
适应疾病:Heart Failure、Heart Failure, Diastolic、Heart Failure, Systolic
研发方:Eli Lilly and Company
- LY4057996
适应疾病:Diabetes Mellitus, Type 1、Diabetes Mellitus, Type 2
研发方:Eli Lilly and Company
- Nab-paclitaxel
适应疾病:Breast Neoplasms、Pancreatic Cancer、Pancreatic Cancer Metastatic
研发方:Merck Sharp & Dohme LLC
- Nemtabrutinib
适应疾病:Leukemia, Lymphocytic, Chronic, B-Cell、Leukemia, Chronic Lymphocytic、Small-Cell Lymphoma
研发方:Merck Sharp & Dohme LLC
- Nipocalimab
适应疾病:Lupus Erythematosus, Systemic、Myasthenia Gravis
研发方:Janssen Research & Development, LLC
- Obinutuzumab
适应疾病:Non-Hodgkin Lymphoma、Burkitt Lymphoma、Diffuse Large B-Cell Lymphoma
研发方:New York Medical College
- Olutasidenib
适应疾病:Acute Myeloid Leukemia、Chronic Myelomonocytic Leukemia、Myelodysplastic Syndrome
研发方:University of California, Davis
- Omeprazole
适应疾病:Active Ulcerative Colitis、Weight Management
研发方:Hoffmann-La Roche
- ORC-13661
适应疾病:Ototoxicity, Drug-Induced
研发方:Kevin Winthrop
- Osimertinib
适应疾病:Lung Cancer、Breast Cancer、Non-Small Cell Lung Cancer
研发方:Bristol-Myers Squibb
- Pacritinib
适应疾病:Myelofibrosis、Post-polycythemia Vera Myelofibrosis、Post-essential Thrombocythemia Myelofibrosis
研发方:John Mascarenhas
- Pb-MP0712
适应疾病:Large Cell Neuroendocrine Carcinoma、Large Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC)、Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
研发方:Molecular Partners AG
- pelabresib
适应疾病:Advanced Malignancies and Hepatic Impairment、Primary Myelofibrosis (PMF)、Post-polycythemia Vera Myelofibrosis (PPV-MF)
研发方:Novartis Pharmaceuticals
- Polatuzumab vedotin
适应疾病:Hodgkin Lymphoma、B-Cell Lymphoma、Relapsed B-cell NHL
研发方:M.D. Anderson Cancer Center
- RAP-219
适应疾病:Focal Seizure、Epilepsy、Focal Epilepsy
研发方:Rapport Therapeutics Inc.
- REGN7508
适应疾病:Venous Thromboembolism (VTE)、Atrial Fibrillation (AF)
研发方:Regeneron Pharmaceuticals
- Ribociclib
适应疾病:Advanced Solid Tumor、HR+/HER2- Breast Cancer、HR+, HER2-, Advanced Breast Cancer
研发方:Avenzo Therapeutics, Inc.
- Rilzabrutinib
适应疾病:Graves' Disease
研发方:Sanofi
- Sarilumab
适应疾病:Polymyalgia Rheumatica
研发方:Sanofi
- Semaglutide Injectable Product
适应疾病:PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries、Obese、Spinal Cord Injuries
研发方:University of Colorado, Denver
- Setidegrasib
适应疾病:Pancreatic Cancer、Metastatic Pancreatic Cancer、Metastatic Pancreatic Adenocarcinoma
研发方:Astellas Pharma Global Development, Inc.
- Sonrotoclax
适应疾病:Chronic Lymphocytic Leukemia、Small Lymphocytic Leukemia、CLL
研发方:Alliance for Clinical Trials in Oncology
- Tacrolimus
适应疾病:Kidney Transplant Rejection、Acute Leukemia、Acute Lymphoblastic Leukemia
研发方:Sanofi
- Telisotuzumab Adizutecan
适应疾病:Non Small Cell Lung Carcinoma、c-MET、Non-Small Cell Lung Cancer
研发方:AbbVie
- Temozolomide
适应疾病:Glioblastoma、Relapsed/Refractory Primary Central Nervous System Lymphoma
研发方:GT Medical Technologies, Inc.
- Tezepelumab
适应疾病:Chronic Obstructive Pulmonary Disease (COPD)、Cardiovascular Events、MACE
研发方:AstraZeneca
- Tocilizumab
适应疾病:Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma、Multiple Myeloma
研发方:Hoffmann-La Roche
- Xeomin
适应疾病:Episodic Migraine、Chronic Migraine
研发方:Merz Therapeutics GmbH
- 11C-MC1
适应疾病:Parkinson's Disease、Dementia、Alzheimer's Disease
研发方:National Institute of Mental Health (NIMH)
- 11C-PS13
适应疾病:Parkinson's Disease、Dementia、Alzheimer's Disease
研发方:National Institute of Mental Health (NIMH)
- 14C-labeled ASP3082
适应疾病:Healthy Volunteer
研发方:Astellas Pharma Global Development, Inc.
- 18f-florbetaben
适应疾病:Parkinson's Disease、Dementia、Alzheimer's Disease
研发方:National Institute of Mental Health (NIMH)
- 18F-fluciclovine
适应疾病:Multiple Myeloma、Newly Diagnosed Multiple Myeloma (NDMM)、Relapsed and/or Refractory Multiple Myeloma (RRMM)
研发方:National Cancer Institute (NCI)
- 18F-PSMA-1007
适应疾病:Prostate Cancer
研发方:University of Alberta
- 5-Hydroxytryptophan
适应疾病:Mild or Moderate Asthma With Allergic Sensitization
研发方:Indiana University
- AAA617
适应疾病:PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
研发方:Novartis Pharmaceuticals
- AAA817
适应疾病:Prostate Cancer
研发方:Novartis Pharmaceuticals
- ABBV-324
适应疾病:Hepatocellular Cancer、Squamous-Cell Non-Small Cell Lung Cancer
研发方:AbbVie
- ABBV-438
适应疾病:Multiple Myeloma
研发方:AbbVie
- Abemaciclib
适应疾病:Anatomic Stage III Breast Cancer AJCC v8、Anatomic Stage IV Breast Cancer AJCC v8、Locally Advanced Unresectable HER2-Negative Breast Carcinoma
研发方:University of Washington
- Abraxane
适应疾病:Gastric or Gastroesophageal Junction Adenocarcinoma、Pancreatic Ductal Adenocarcinoma、Biliary Tract Cancer (BTC)
研发方:Phanes Therapeutics
- Abrocitinib
适应疾病:Eczema
研发方:Pfizer
- ACE-232
适应疾病:Prostate Cancer (Adenocarcinoma)、mCRPC (Metastatic Castration-resistant Prostate Cancer)
研发方:Acerand Therapeutics (Hong Kong) Limited
- Acetaminophen
适应疾病:Diabetes Mellitus, Type 1、Overweight、Obesity
研发方:Eli Lilly and Company
- Acoramidis
适应疾病:Transthyretin Amyloid Cardiomyopathy
研发方:Bayer
- Actinium Ac 225-DOTA-Daratumumab
适应疾病:Acute Lymphoblastic Leukemia、Acute Myeloid Leukemia、Myelodysplastic Syndrome
研发方:City of Hope Medical Center
- Adagrasib
适应疾病:Carcinoma, Non-Small-Cell Lung
研发方:Mirati Therapeutics Inc.
- Adalimumab Biosimilars
适应疾病:Major Depressive Disorder (MDD)
研发方:Daniel Moriarity
- ADELANTE
适应疾病:HIV/AIDS
研发方:Massachusetts General Hospital
- ADX-097
适应疾病:IgA Nephropathy、Lupus Nephritis (LN)、C3 (Complement Component 3) Glomerulopathy
研发方:Akebia Therapeutics
- Aflibercept
适应疾病:Diabetic Retinopathy、Macular Edema
研发方:Merck Sharp & Dohme LLC
- AHB-137
适应疾病:Hepatitis B, Chronic
研发方:AusperBio Therapeutics Inc.
- ALE.P02
适应疾病:Squamous Non-small-cell Lung Cancer、Head and Neck Squamous Cell Carcinoma、Cervical Squamous Cell Carcinoma
研发方:Alentis Therapeutics AG
- Alectinib
适应疾病:Non-small Cell Lung Cancer、Anaplastic Lymphoma Kinase-positive
研发方:Nuvalent Inc.
- Allogeneic thyTreg 10.000.000
适应疾病:Systemic Inflammatory Response Syndrome
研发方:Hospital General Universitario Gregorio Marañon
- ALLR3
适应疾病:ACUTE LYMPHOBLASTIC LEUKEMIA
研发方:Pfizer
- ALN-5288
适应疾病:Alzheimer's Disease
研发方:Alnylam Pharmaceuticals
- ALN-AGT01 RVR
适应疾病:Hypertension
研发方:Alnylam Pharmaceuticals
- ALN-HTT02
适应疾病:Huntington's Disease
研发方:Alnylam Pharmaceuticals
- ALN-PNP
适应疾病:Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
研发方:Regeneron Pharmaceuticals
- ALN-SNCA
适应疾病:Parkinsons Disease
研发方:Regeneron Pharmaceuticals
- Alpelisib
适应疾病:Advanced Malignant Solid Neoplasm、Anatomic Stage III Breast Cancer AJCC v8、Anatomic Stage IV Breast Cancer AJCC v8
研发方:National Cancer Institute (NCI)
- ALS20
适应疾病:Beta-Thalassemia
研发方:Children's Hospital of Philadelphia
- ALV-100
适应疾病:Overweight , Obesity、Adults
研发方:Alveus Therapeutics, Inc.
- Amitriptyline
适应疾病:Headache、Headache Disorders、Headache, Migraine
研发方:Children's Hospital Medical Center, Cincinnati
- Amivantamab
适应疾病:Colorectal Neoplasms
研发方:Janssen Research & Development, LLC
- AMO959
适应疾病:PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
研发方:Novartis Pharmaceuticals
- AMT-191
适应疾病:Fabry Disease
研发方:UniQure Biopharma B.V.
- Anastrozole
适应疾病:Anatomic Stage III Breast Cancer AJCC v8、Anatomic Stage IV Breast Cancer AJCC v8、Locally Advanced Unresectable HER2-Negative Breast Carcinoma
研发方:University of Washington
- Angiotensin-
适应疾病:Obesity、Hypertension
研发方:Milton S. Hershey Medical Center
- Anktiva
适应疾病:Long COVID、Long COVID Syndrome、Long Covid 19
研发方:ImmunityBio, Inc.
- Ansastrozole
适应疾病:Early Breast Cancer
研发方:Novartis Pharmaceuticals
- AP31969
适应疾病:Atrial Fibrillation (AF)
研发方:Acesion Pharma
- AQUA07
适应疾病:ALK Positive Non-small Cell Lung Cancer
研发方:Chugai Pharmaceutical
- ARO-INHBE
适应疾病:Obesity
研发方:Arrowhead Pharmaceuticals
- ARO-MAPT
适应疾病:Alzheimer Disease、Alzheimer Disease, Early Onset
研发方:Arrowhead Pharmaceuticals
- ARPI
适应疾病:Prostate Cancer
研发方:Novartis Pharmaceuticals
- Asciminib
适应疾病:Philadelphia Chromosome-Positive、Acute Lymphoblastic Leukemia
研发方:M.D. Anderson Cancer Center
- ASP2767
适应疾病:Glaucoma
研发方:Astellas Pharma Global Development, Inc.
- ASP546C
适应疾病:Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma、Pancreatic Adenocarcinoma
研发方:Astellas Pharma Global Development, Inc.
- Aspirin
适应疾病:Diabete Type 2、Cardiovascular Diseases
研发方:Montreal Heart Institute
- atezolizumab
适应疾病:Small Cell Lung Cancer (SCLC)、Extensive-stage Small Cell Lung Cancer (ES-SCLC)
研发方:Boehringer Ingelheim
- ATH-063
适应疾病:Ulcerative Colitis、Inflammatory Bowel Diseases、Autoimmune Diseases
研发方:Athos Therapeutics Inc
- Atovaquone
适应疾病:Ovarian High Grade Serous Adenocarcinoma、Platinum-Resistant Ovarian Carcinoma
研发方:Emory University
- ATR 1072
适应疾病:Cardiac Glycogenosis、Cardiomyopathy、Hypertrophic
研发方:Atrium Therapeutics
- AU-007
适应疾病:Advanced Solid Tumor、Metastatic Cancer、Cutaneous Melanoma
研发方:Aulos Bioscience, Inc.
- AUBE00
适应疾病:Solid Tumors
研发方:Chugai Pharmaceutical
- AVA6103
适应疾病:Vulvar Adenocarcinoma、PDAC - Pancreatic Ductal Adenocarcinoma、Gastric Adenocarcinoma
研发方:Avacta Life Sciences Ltd
- Avelumab
适应疾病:Advanced Solid Tumor、Metastatic Cancer、Cutaneous Melanoma
研发方:Aulos Bioscience, Inc.
- AVZO-021
适应疾病:Advanced Solid Tumor、HR+/HER2- Breast Cancer、HR+, HER2-, Advanced Breast Cancer
研发方:Avenzo Therapeutics, Inc.
- AWARE
适应疾病:Asthma、COPD、Cystic Fibrosis
研发方:Indiana University
- Axatilimab
适应疾病:Myelofibrosis (MF)、Chronic Myelomonocytic Leukemia (CMML)
研发方:M.D. Anderson Cancer Center
- Axi-cel
适应疾病:B Cell Lymphoma
研发方:M.D. Anderson Cancer Center
- AZD0292
适应疾病:Bronchiectasis With Pseudomonas Aeruginosa Colonization
研发方:AstraZeneca
- AZD0901
适应疾病:Gastric Cancer、Gastroesophageal Junction Cancer、Biliary Tract Cancer
研发方:AstraZeneca
- AZD3632
适应疾病:Acute Lymphoblastic Leukaemia、Acute Myeloid Leukaemia、Higher-risk Myelodysplastic Syndromes
研发方:AstraZeneca
- azenosertib
适应疾病:High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
研发方:K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Barrigel
适应疾病:Prostate Cancer
研发方:Palette Life Sciences, Inc.
- Baxdrostat/dapagliflozin
适应疾病:Chronic Kidney Disease and Hypertension
研发方:AstraZeneca
- BAY 3771249
适应疾病:Advanced/Metastatic Colorectal Adenocarcinoma
研发方:Bayer
- BBT001
适应疾病:Atopic Dermatitis
研发方:Bambusa Therapeutics
- Berobenatide
适应疾病:Apnea、Sleep Disorders、Overweight and/or Obesity
研发方:Pfizer
- BHB810
适应疾病:Gastric Cancer、Gastric Adenocarcinoma、Gastric (Stomach) Cancer
研发方:BigHat Biosciences, Inc.
- BI 3034701
适应疾病:Overweight、Obesity
研发方:Boehringer Ingelheim
- BI 3822971
适应疾病:Solid Tumours
研发方:Boehringer Ingelheim
- BI 765423
适应疾病:Idiopathic Pulmonary Fibrosis
研发方:Boehringer Ingelheim
- BI-1206
适应疾病:Indolent B-Cell Non-Hodgkin Lymphoma
研发方:BioInvent International AB
- Bimekizumab
适应疾病:Moderate to Severe Plaque Psoriasis、Psoriatic Arthritis、Axial Spondyloarthritis
研发方:UCB Biopharma SRL
- Binimetinib
适应疾病:Advanced Malignant Solid Neoplasm、Anatomic Stage III Breast Cancer AJCC v8、Anatomic Stage IV Breast Cancer AJCC v8
研发方:National Cancer Institute (NCI)
- Bisoprolol
适应疾病:Takotsubo Cardiomyopathy
研发方:University of Edinburgh
- Bleximenib
适应疾病:Acute Myeloid Leukemia
研发方:Stichting Hemato-Oncologie voor Volwassenen Nederland
- Bmab1700
适应疾病:Melanoma
研发方:Biocon Biologics UK PLC
- BMN 333
适应疾病:Achondroplasia
研发方:BioMarin Pharmaceutical
- BMS-986504
适应疾病:Metastatic Non-small Cell Lung Cancer With MTAP Deletion
研发方:Bristol-Myers Squibb
- BMS-986507
适应疾病:Lung Cancer、Breast Cancer
研发方:Bristol-Myers Squibb
- BMS-986528
适应疾病:Arthritis, Rheumatoid
研发方:Bristol-Myers Squibb
- BQ-123
适应疾病:Chronic Obstructive Pulmonary Disease、Pulmonary Artery Hypertension、Heart Failure
研发方:D. Walter Wray
- Brachytherapy
适应疾病:Locally Advanced Cervical Adenocarcinoma、Locally Advanced Cervical Adenosquamous Carcinoma、Locally Advanced Cervical Squamous Cell Carcinoma
研发方:National Cancer Institute (NCI)
- Broncho-Vaxom
适应疾病:Wheezing、LRTI、Premature
研发方:Franciscus Gasthuis
- Budesonide
适应疾病:Asthma
研发方:Novartis Pharmaceuticals
- Budigalimab
适应疾病:Non Small Cell Lung Carcinoma、c-MET
研发方:AbbVie
- Bupivacain
适应疾病:Postoperative Pain、Fibroid Uterus
研发方:Joseph Findley MD
- Busulfan
适应疾病:GATA2、Immunodeficiency、MDS
研发方:National Cancer Institute (NCI)
- BYN-001
适应疾病:Atopic Dermatitis、Healthy Participants
研发方:Bionyra Pharma
- C7R.CD30.CAR-EBVST cells
适应疾病:CD30-Positive Diffuse Large B-Cell Lymphoma、Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type、Anaplastic Large Cell Lymphoma, ALK-Positive
研发方:Baylor College of Medicine
- Cabazitaxel
适应疾病:Metastatic Castration-resistant Prostate Cancer
研发方:Amgen
- Cabozantinib S-malate
适应疾病:Bladder Adenocarcinoma、Bladder Clear Cell Adenocarcinoma、Bladder Mixed Adenocarcinoma
研发方:National Cancer Institute (NCI)
- Caffeine
适应疾病:Active Ulcerative Colitis
研发方:Hoffmann-La Roche
- Cagrisema
适应疾病:Obesity、Type 2 Diabetes
研发方:Novo Nordisk A/S
- Calderasib
适应疾病:Colon Adenocarcinoma、Rectal Adenocarcinoma
研发方:Merck Sharp & Dohme LLC
- Camlipixant
适应疾病:Irritable Bowel Syndrome
研发方:GlaxoSmithKline
- Capox
适应疾病:Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
研发方:Bristol-Myers Squibb
- Carmustine
适应疾病:Autologous Stem Cell Transplant、Classic Hodgkin Lymphoma
研发方:Masonic Cancer Center, University of Minnesota
- Carotuximab
适应疾病:Castration-resistant Prostate Cancer
研发方:Edwin Posadas, MD
- CART19
适应疾病:SLE、Systemic Lupus Erythematosus (SLE)、CAR T Cell
研发方:Children's Hospital of Philadelphia
- CBL-514
适应疾病:Subcutaneous Fat
研发方:Caliway Biopharmaceuticals Co., Ltd.
- CD40.HIVRI.Env
适应疾病:HIV Infections
研发方:National Institute of Allergy and Infectious Diseases (NIAID)
- Cellgram-LC
适应疾病:Alcoholic Cirrhosis
研发方:Pharmicell Co., Ltd.
- Cemdisiran
适应疾病:Paroxysmal Nocturnal Hemoglobinuria
研发方:Regeneron Pharmaceuticals
- Cemiplimab
适应疾病:Non-Small Cell Lung Cancer
研发方:ETOP IBCSG Partners Foundation
- Cemsidomide
适应疾病:Multiple Myeloma、Relapsed/Refractory Multiple Myeloma
研发方:C4 Therapeutics, Inc.
- Cevostamab
适应疾病:Multiple Myeloma
研发方:Genentech, Inc.
- Cisatracurium
适应疾病:Post Operative Pulmonary Complications、Neuromuscular Blockade、General Anesthesia
研发方:The University of Texas Medical Branch, Galveston
- CITY-FXI
适应疾病:Factor V Leiden、Prothrombin G20210A、Venous Thromboembolism (VTE)
研发方:City Therapeutics
- clofutriben
适应疾病:Type 2 Diabetes、Cortisol Excess
研发方:Sparrow Pharmaceuticals
- Cobicistat
适应疾病:AML, Adult
研发方:Stichting Hemato-Oncologie voor Volwassenen Nederland
- Colchicine
适应疾病:Diabete Type 2、Cardiovascular Diseases
研发方:Montreal Heart Institute
- Colonoscopy
适应疾病:Colorectal Polyp、Colorectal Neoplasms、Colorectal Adenoma
研发方:Dartmouth-Hitchcock Medical Center
- Concerta
适应疾病:ADHD
研发方:Stéphanie Baggio
- CPX-351
适应疾病:Acute Myeloid Leukemia、TP53
研发方:Masonic Cancer Center, University of Minnesota
- creon 35.000 Ph.U
适应疾病:Unresectable Pancreatic Cancer
研发方:Hospital Clinico Universitario de Santiago
- CSL300
适应疾病:End Stage Kidney Disease
研发方:CSL Behring
- CT-202
适应疾病:Triple Negative Breast Cancer (TNBC)、Colorectal Cancer、Urothelial Cancer
研发方:Context Therapeutics Inc.
- CTX112
适应疾病:Warm Autoimmune Hemolytic Anemia (WAIHA)、ITP - Immune Thrombocytopenia、Warm Autoimmune Hemolytic Anemia
研发方:CRISPR Therapeutics AG
- CTX310
适应疾病:Cardiovascular、Metabolic Disease、Dyslipidemias
研发方:CRISPR Therapeutics AG
- Cystoscopy
适应疾病:Muscle Invasive Bladder Urothelial Carcinoma、Muscle Invasive Renal Pelvis Urothelial Carcinoma、Muscle Invasive Ureter Urothelial Carcinoma
研发方:National Cancer Institute (NCI)
- Dabogratinib TBD
适应疾病:Low Grade Upper Tract Urothelial Carcinoma
研发方:Tyra Biosciences, Inc
- DailyDose
适应疾病:Type 1 Diabetes (T1D)
研发方:Oregon Health and Science University
- Dapagliflozin
适应疾病:Renal Insufficiency, Chronic
研发方:AstraZeneca
- Darolutamide
适应疾病:Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
研发方:Novartis Pharmaceuticals
- Datopotamab deruxtecan
适应疾病:Endometrial Cancer、Gastric Cancer、Metastatic Castration-resistant Prostate Cancer
研发方:AstraZeneca
- Daunorubicin Hydrochloride
适应疾病:Core Binding Factor Acute Myeloid Leukemia
研发方:National Cancer Institute (NCI)
- Debio 1562M
适应疾病:Acute Myeloid Leukemia
研发方:Debiopharm International SA
- Degarelix
适应疾病:Castration Levels of Testosterone、Metastatic Prostatic Adenocarcinoma、Stage IV Prostate Cancer AJCC v8
研发方:SWOG Cancer Research Network
- Degludec
适应疾病:Diabetes Mellitus, Type 1、Diabetes Mellitus, Type 2
研发方:Eli Lilly and Company
- Denecimig
适应疾病:Haemophilia A
研发方:Novo Nordisk A/S
- Denikitug
适应疾病:Advanced Microsatellite Stable Colorectal Cancer
研发方:Gilead Sciences
- Deutivacaftor
适应疾病:Cystic Fibrosis
研发方:Vertex Pharmaceuticals Incorporated
- Dexrazoxane
适应疾病:DLBCL - Diffuse Large B Cell Lymphoma
研发方:Stichting Hemato-Oncologie voor Volwassenen Nederland
- Dextromethorphan
适应疾病:Active Ulcerative Colitis
研发方:Hoffmann-La Roche
- Dextrose
适应疾病:Shift Work Schedule、Circadian Rhythm、Insulin Resistance
研发方:Washington State University
- Diclofenac
适应疾病:Interaction
研发方:Washington State University
- Donepezil
适应疾病:Osteoporosis
研发方:Duke University
- Doravirine
适应疾病:Human Immunodeficiency Virus (HIV) Infection
研发方:Merck Sharp & Dohme LLC
- Dotinurad
适应疾病:Gout
研发方:Crystalys Therapeutics
- Doxorubicin Hydrochloride
适应疾病:Renal Pelvis and Ureter Urothelial Carcinoma
研发方:National Cancer Institute (NCI)
- DT120
适应疾病:Major Depressive Disorder
研发方:Definium Therapeutics US, Inc.
- Dupilumab
适应疾病:Chronic Obstructive Pulmonary Disease
研发方:Sanofi
- Dupilumab Prefilled Syringe
适应疾病:Asthma Control
研发方:Université de Sherbrooke
- Duvakitug
适应疾病:Ulcerative Colitis
研发方:Sanofi
- Echocardioraphy
适应疾病:Acute Lymphatic Leukemia、Lymphoma
研发方:University of Erlangen-Nürnberg Medical School
- Eflapegrastim
适应疾病:Solid Tumors、Lymphoma
研发方:Spectrum Pharmaceuticals, Inc
- Efruxifermin
适应疾病:NASH With Fibrosis、MASH With Fibrosis
研发方:Akero Therapeutics, Inc
- Elironrasib
适应疾病:Non-Small Cell Lung Cancer (NSCLC)、Colorectal Cancer、Pancreatic Ductal Adenocarcinoma
研发方:Revolution Medicines, Inc.
- ELLIPTA
适应疾病:Asthma
研发方:GlaxoSmithKline
- Eloralintide
适应疾病:Sleep Apnea, Obstructive、Obesity、Overweight
研发方:Eli Lilly and Company
- Elritercept
适应疾病:Myelodysplastic Syndromes
研发方:Takeda
- Eltrekibart
适应疾病:Ulcerative Colitis、Ulcerative Colitis Chronic
研发方:Eli Lilly and Company
- Emavusertib
适应疾病:Relapsed Hematologic Malignancy、Refractory Hematologic Malignancy、Relapsed Primary Central Nervous System Lymphoma
研发方:Curis, Inc.
- Empagliflozin
适应疾病:Obesity、Vascular Health
研发方:VA Office of Research and Development
- Empasiprubart
适应疾病:AChR-Ab Seropositive Generalized Myasthenia Gravis、Myasthenia Gravis、MG
研发方:argenx
- Enasidenib
适应疾病:Myelodysplastic Syndrome
研发方:National Cancer Institute (NCI)
- Enfortumab Vedotin
适应疾病:Muscle-invasive Bladder Cancer
研发方:Astellas Pharma Global Development, Inc.
- Enoxaparin
适应疾病:Venous Thromboembolism (VTE)
研发方:Regeneron Pharmaceuticals
- Epcoritamab
适应疾病:Large B Cell Lymphoma
研发方:Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Eprex
适应疾病:MDS、Myelodysplastic Syndromes
研发方:Groupe Francophone des Myelodysplasies
- Eribulin
适应疾病:Breast Neoplasms
研发方:BioNTech SE
- Ersodetug
适应疾病:Tumor Hyperinsulinism (Tumor HI)
研发方:Rezolute
- EsoCheck
适应疾病:Barrett Esophagus、Gastroesophageal Reflux、Esophageal Adenocarcinoma
研发方:Case Comprehensive Cancer Center
- EsoGuard
适应疾病:Barrett Esophagus、Gastroesophageal Reflux、Esophageal Adenocarcinoma
研发方:Case Comprehensive Cancer Center
- Etrasimod
适应疾病:Ulcerative Colitis
研发方:Pfizer
- Everolimus
适应疾病:Metastatic Digestive System Neuroendocrine Tumor G1、Metastatic Digestive System Neuroendocrine Tumor G2、Unresectable Digestive System Neuroendocrine Tumor G1
研发方:National Cancer Institute (NCI)
- Exenatide
适应疾病:Pancreatic Cancer
研发方:AstraZeneca
- F-18 16 Alpha-Fluoroestradiol
适应疾病:Anatomic Stage IV Breast Cancer AJCC v8、Estrogen Receptor-Positive Breast Carcinoma、Metastatic Breast Carcinoma
研发方:City of Hope Medical Center
- F8IL10
适应疾病:Rheumatoid Arthritis (RA)
研发方:Philogen S.p.A.
- Fenebrutinib
适应疾病:Relapsing Multiple Sclerosis
研发方:Hoffmann-La Roche
- FEPPA
适应疾病:Asthma
研发方:University of Wisconsin, Madison
- FibroScan
适应疾病:Heart Failure、Heart Failure - NYHA II - IV
研发方:Echosens
- Finerenone
适应疾病:Chronic Kidney Disease、Proteinuria、Children
研发方:Bayer
- Fitusiran
适应疾病:Hemophilia A
研发方:Sanofi
- Floxuridine
适应疾病:Metastatic Colorectal Carcinoma、Metastatic Malignant Neoplasm in the Liver、Stage IV Colorectal Cancer AJCC v8
研发方:ECOG-ACRIN Cancer Research Group
- Fludrocortisone acetate
适应疾病:Metastatic Castration-resistant Prostate Cancer (mCRPC)、Prostatic Neoplasms
研发方:Merck Sharp & Dohme LLC
- Fluoropyrimidine
适应疾病:Autoimmune Disease、Crohn Disease、Dermatomyositis
研发方:National Cancer Institute (NCI)
- Flutamide
适应疾病:Castration Levels of Testosterone、Metastatic Prostatic Adenocarcinoma、Stage IV Prostate Cancer AJCC v8
研发方:SWOG Cancer Research Network
- FOLFIRI
适应疾病:Ras-mutated Metastatic Colorectal Cancer、mCRC、MSS Metastatic Colorectal Cancer
研发方:Oncolytics Biotech
- Folfox
适应疾病:Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
研发方:Bristol-Myers Squibb
- Food-Body-Mind
适应疾病:Mental Health Wellness、Emotional Problem、Behavioral Problem of Child
研发方:Michigan State University
- Fosmanogepix
适应疾病:Invasive Mold Infections
研发方:Basilea Pharmaceutica
- Fulvestrant
适应疾病:Advanced Solid Tumor、HR+/HER2- Breast Cancer、HR+, HER2-, Advanced Breast Cancer
研发方:Avenzo Therapeutics, Inc.
- Furosemide
适应疾病:Pulmonary Edema、Congestive Heart Failure、Acute Heart Failure
研发方:Copenhagen University Hospital, Rigshospitalet
- GHZ339
适应疾病:Atopic Dermatitis
研发方:Novartis Pharmaceuticals
- GI-101
适应疾病:Advanced Solid Tumor、Metastatic Solid Tumor、Cervical Cancer
研发方:GI Innovation, Inc.
- GI-101A
适应疾病:Advanced Solid Tumor、Metastatic Solid Tumor、Cervical Cancer
研发方:GI Innovation, Inc.
- Glepaglutide
适应疾病:Short Bowel Syndrome
研发方:Zealand Pharma
- Glufosfamide
适应疾病:Metastatic Pancreatic Adenocarcinoma
研发方:Eleison Pharmaceuticals LLC.
- Golidocitinib
适应疾病:Peripheral T Cell Lymphoma
研发方:M.D. Anderson Cancer Center
- Goserelin
适应疾病:Early Breast Cancer
研发方:Novartis Pharmaceuticals
- GS-0415
适应疾病:HIV -1 Infection
研发方:Gilead Sciences
- GS-4571
适应疾病:Weight Management
研发方:Gilead Sciences
- HBS-104
适应疾病:Sleep Deprivation
研发方:Harmony Biosciences Management, Inc.
- HFA-134a
适应疾病:Asthma
研发方:GlaxoSmithKline
- HFA-152a
适应疾病:Asthma
研发方:GlaxoSmithKline
- Home
适应疾病:Quality of Life (QOL)、Nutrition、Physical Activity
研发方:Chiba University
- HRS-7525
适应疾病:Prostate Cancer
研发方:Jiangsu HengRui Medicine Co., Ltd.
- hu1418K322A + Temozolomide + Irinotecan
适应疾病:High-Risk Neuroblastoma
研发方:Renaissance Pharma Ltd.
- Hydrocortisone
适应疾病:Metastatic Castration-resistant Prostate Cancer (mCRPC)、Prostatic Neoplasms
研发方:Merck Sharp & Dohme LLC
- Hydroxytyrosol
适应疾病:Advanced or Metastatic CRC
研发方:The Methodist Hospital Research Institute
- Hydroxyurea
适应疾病:Acute Myeloid Leukemia With Gene Mutations
研发方:PETHEMA Foundation
- Hyperfine
适应疾病:Acute Brain Injury、Extracorporeal Membrane Oxygenation Complication、Hypoxia-Ischemia, Brain
研发方:Children's Mercy Hospital Kansas City
- Ianalumab
适应疾病:Diffuse Cutaneous Systemic Sclerosis
研发方:Novartis Pharmaceuticals
- IB-001
适应疾病:Chronic Hepatitis B Virus Infection
研发方:IntegerBio
- Iberdomide
适应疾病:Myeloma、Multiple Myeloma、Refractory Multiple Myeloma
研发方:Omar Nadeem, MD
- IDE397
适应疾病:NSCLC Adenocarcinoma、Gastroesophageal Cancer (GC)、Gastric Adenocarcinoma
研发方:IDEAYA Biosciences
- IDE892
适应疾病:NSCLC Adenocarcinoma、Gastroesophageal Cancer (GC)、Gastric Adenocarcinoma
研发方:IDEAYA Biosciences
- Ifinatamab deruxtecan
适应疾病:Prostate Cancer、Prostatic Neoplasms
研发方:Merck Sharp & Dohme LLC
- Ifosfamide
适应疾病:Non-Hodgkin Lymphoma、Burkitt Lymphoma、Diffuse Large B-Cell Lymphoma
研发方:New York Medical College
- IgPro20
适应疾病:Secondary Immune Deficiency
研发方:CSL Behring
- IKS014
适应疾病:Breast Cancer、Gastric Cancer、Gastroesophageal-junction Cancer
研发方:Iksuda Therapeutics Ltd.
- imatinib
适应疾病:Inherited Bone Marrow Failure Syndrome、Familial Platelet Disorder With Predisposition to Myeloid Malignancies
研发方:National Cancer Institute (NCI)
- Impella
适应疾病:Coronary Artery Disease、High Risk Percutaneous Coronary Intervention、Interventional Cardiology
研发方:Supira Medical
- Imzokitug
适应疾病:Locally Advanced Non-Small Cell Lung Cancer (NSCLC)、Metastatic Non-Small Cell Lung Cancer (NSCLC)
研发方:Bristol-Myers Squibb
- Inclisiran
适应疾病:Heterozygous or Homozygous Familial Hypercholesterolemia
研发方:Novartis Pharmaceuticals
- Inotuzumab ozogamicin
适应疾病:ACUTE LYMPHOBLASTIC LEUKEMIA
研发方:Pfizer
- insulin
适应疾病:Shift Work Schedule、Circadian Rhythm、Insulin Resistance
研发方:Washington State University
- Intismeran
适应疾病:Non-small Cell Lung Cancer
研发方:Merck Sharp & Dohme LLC
- iTBS
适应疾病:Schizophrenia、Schizo Affective Disorder、Schizophreniform Disorders
研发方:Northwell Health
- Ivonescimab
适应疾病:Thymus Carcinoma
研发方:Jonsson Comprehensive Cancer Center
- IVUS
适应疾病:Coronary Artery Disease、Coronary Artery Disease Risk High、Complex Coronary Artery Disease
研发方:ECRI bv
- JAB-23E73
适应疾病:Advanced Solid Tumors
研发方:Jacobio Pharmaceuticals Co., Ltd.
- JADE201
适应疾病:Rhematoid Arthritis
研发方:Jade Biosciences, Inc.
- JNJ-87189401
适应疾病:Metastatic Castration-resistant Prostatic Neoplasms
研发方:Janssen Research & Development, LLC
- JNJ-88545223
适应疾病:Arthritis, Psoriatic
研发方:Janssen Research & Development, LLC
- JNJ-90301900
适应疾病:Carcinoma, Non-Small-Cell Lung
研发方:Johnson & Johnson Enterprise Innovation Inc.
- JUR-003
适应疾病:Metastatic Castration Resistant Prostate Cancer、Oligometastatic Prostate Cancer (OMPC)、Metastatic Hormone Sensitive Prostate Cancer
研发方:Juri Biosciences, Inc.
- JX10
适应疾病:Acute Ischemic Stroke
研发方:Corxel Pharmaceuticals
- Ketamine
适应疾病:Depression - Major Depressive Disorder、Treatment-resistant Depression (TRD)、rTMS
研发方:Weill Medical College of Cornell University
- KK2223
适应疾病:T-cell NHL (PTCL or CTCL)
研发方:Kyowa Kirin, Inc.
- KT-621
适应疾病:Eosinophilic Asthma
研发方:Kymera Therapeutics, Inc.
- kTMP
适应疾病:Stroke、Chronic Stroke Patients、Arm Weakness as a Consequence of Stroke
研发方:Magnetic Tides
- l-leucovorin
适应疾病:Gastric Cancer、Gastroesophageal Junction Cancer、Biliary Tract Cancer
研发方:AstraZeneca
- LAE103
适应疾病:Overweight and Obesity
研发方:Laekna Limited
- LAM-001
适应疾病:Pulmonary Hypertension Due to Lung Diseases and Hypoxia
研发方:IRulya Therapeutics Inc.
- LBT-3627
适应疾病:Parkinson Disease
研发方:Longevity Biotech Australia Pty Ltd (subsidiary)
- Lenbelintide
适应疾病:Obesity or Overweight、Weight-Related Comorbidity、With/Without Diabetes Mellitus, Type 2
研发方:AstraZeneca
- Leucapheresis
适应疾病:HIV-1-infection、HIV Seropositivity
研发方:University Hospital, Ghent
- Leuprolide
适应疾病:Early Breast Cancer
研发方:Novartis Pharmaceuticals
- Lexapro
适应疾病:Irritable Bowel Syndrome With Constipation
研发方:University of Michigan
- LFD-200
适应疾病:Rheumatoid Arthritis
研发方:Lifordi Immunotherapeutics, Inc.
- Linvoseltamab
适应疾病:Relapsed Refractory Multiple Myeloma (RRMM)
研发方:Regeneron Pharmaceuticals
- LNP023
适应疾病:Primary IgA Nephropathy
研发方:Novartis Pharmaceuticals
- Loncastuximab
适应疾病:Diffuse Large B-cell Lymphoma
研发方:The University of Texas Health Science Center at San Antonio
- Loncastuximab Tesirine
适应疾病:Recurrent Diffuse Large B-Cell Lymphoma、Recurrent Grade 3b Follicular Lymphoma、Recurrent High Grade B-Cell Lymphoma
研发方:City of Hope Medical Center
- Lorlatinib
适应疾病:ALK Positive Non-small Cell Lung Cancer
研发方:Chugai Pharmaceutical
- LTZ-232
适应疾病:Colorectal Cancer、Advanced/Metastatic Solid Tumor、Solid Tumor (Phase I)
研发方:LTZ Therapeutics, Inc.
- Lu-PSMA-617
适应疾病:Metastatic Prostate Cancer、Metastatic Castration-resistant Prostate Cancer
研发方:Case Comprehensive Cancer Center
- Lumateperone
适应疾病:Major Depressive Disorder
研发方:Intra-Cellular Therapies, Inc.
- Lunsekimig
适应疾病:Chronic Obstructive Pulmonary Disease
研发方:Sanofi
- Luspatercept
适应疾病:MDS、Myelodysplastic Syndromes
研发方:Groupe Francophone des Myelodysplasies
- LY3439539
适应疾病:Alzheimer Disease
研发方:Eli Lilly and Company
- LY3537031
适应疾病:Alcohol Use Disorder
研发方:Eli Lilly and Company
- LY3954068
适应疾病:Alzheimer Disease
研发方:Eli Lilly and Company
- LY4329090
适应疾病:Obesity、Overweight
研发方:Eli Lilly and Company
- LY4395089
适应疾病:Colitis, Ulcerative、Crohn Disease
研发方:Eli Lilly and Company
- LYL273
适应疾病:Colorectal Cancer
研发方:Lyell Immunopharma, Inc.
- Macitentan
适应疾病:Hypertension, Pulmonary
研发方:Actelion
- Melphalan
适应疾病:Multiple Myeloma
研发方:Memorial Sloan Kettering Cancer Center
- Memantine
适应疾病:Osteoporosis
研发方:Duke University
- MEN1703
适应疾病:Non-Hodgkin Lymphoma, B-cell
研发方:Ryvu Therapeutics SA
- Metarrestin
适应疾病:Advanced Solid Tumors、Metastatic Pancreatic Cancer、Pediatric Solid Tumor
研发方:National Cancer Institute (NCI)
- Methotrexate
适应疾病:Acute Lymphoblastic Leukemia
研发方:Northside Hospital, Inc.
- MGC030
适应疾病:Urothelial Cancer、GastroEsophageal Cancer、Colorectal Cancer
研发方:MacroGenics
药物名称取自 ClinicalTrials.gov 公开登记信息,多为英文通用名或研发代号。本页仅作信息整理,不构成医疗建议,是否适合用药请咨询专业医生。